Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,000
Closed -$2.17M 360
2020
Q3
$2.17M Sell
10,000
-5,175
-34% -$1.13M 0.15% 178
2020
Q2
$3.3M Sell
15,175
-1,395
-8% -$296K 0.3% 118
2020
Q1
$3.48M Hold
16,570
0.42% 102
2019
Q4
$3.48M Hold
16,570
0.42% 97
2019
Q3
$3.42M Sell
16,570
-15
-0.1% -$3.08K 0.44% 89
2019
Q2
$3.38M Buy
16,585
+2,500
+18% +$509K 0.49% 82
2019
Q1
$2.85M Hold
14,085
0.49% 82
2018
Q4
$2.79M Buy
14,085
+5,550
+65% +$1.09M 0.52% 74
2018
Q3
$1.66M Buy
+8,535
New +$1.65M 0.32% 95

Other funds holding CLNN

Periscope Capital's CLNN Position: Q4 2020 in Review

Periscope Capital sold out of Clene (CLNN) in Q4 2020, closing a stake of 10,000 shares — an estimated $2.17M sold.

Periscope Capital first reported a position in CLNN in Q3 2018 and held it in 9 quarters. The position peaked at $3.48M in Q1 2020. 13 funds tracked by Wall St. Rank hold CLNN as of Q4 2020.

  • Periscope Capital reported no remaining Clene position as of Q4 2020 after selling out during the quarter.
  • Periscope Capital sold 10,000 Clene shares in Q4 2020, an estimated $2.17M.
  • Periscope Capital first reported a position in Clene in Q3 2018 and held it in 9 quarters.
  • Periscope Capital's Clene position peaked at $3.48M in Q1 2020.
  • 13 funds tracked by Wall St. Rank held Clene as of Q4 2020.

Based on Periscope Capital's 13F filing for Q4 2020, filed 10 Feb 2021.